Iron dextran and Atelectasis - a phase IV clinical study of FDA data

Summary:

Atelectasis is reported as a side effect among people who take Iron dextran (iron dextran), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Atelectasis when taking Iron dextran. It is created by eHealthMe based on reports of 994 people who have side effects when taking Iron dextran from the FDA, and is updated regularly.

What is Iron dextran?

Iron dextran has active ingredients of iron dextran. It is often used in anemia. eHealthMe is studying from 1,487 Iron dextran users. Check the latest studies of Iron dextran.

What is Atelectasis?

Atelectasis (partial or complete collapse of the lung) is found to be associated with 1,454 drugs and 1,634 conditions by eHealthMe. Check the latest studies of Atelectasis.

On Jul, 11, 2026

994 people reported to have side effects when taking Iron dextran.
Among them, 12 people (1.21%) have Atelectasis.

Among these 12 people:

How long have people been on Iron dextran when they have Atelectasis? *

What is the gender of people who have Atelectasis when taking Iron dextran? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Atelectasis when taking Iron dextran? *

What are other drugs people take besides Iron dextran? *

What are other side effects people have besides Atelectasis? *

Depression: 11 people, 91.67%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 11 people, 91.67%
Spinal Osteoarthritis (joint cartilage loss in spine): 11 people, 91.67%
Anaemia (lack of blood): 11 people, 91.67%
Osteonecrosis Of Jaw (death of bone of jaw): 11 people, 91.67%
Dyspnea (difficult or laboured breathing): 11 people, 91.67%
Abdominal Pain: 10 people, 83.33%
Fall: 10 people, 83.33%
Nausea (feeling of having an urge to vomit): 10 people, 83.33%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 10 people, 83.33%

What are the existing conditions these people have? *

Anaemia (lack of blood): 10 people, 83.33%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 10 people, 83.33%
Multiple Myeloma (cancer of the plasma cells): 10 people, 83.33%
Joint Pain: 1 person, 8.33%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 8.33%
Blood Triglycerides Decreased: 1 person, 8.33%
Diarrhea: 1 person, 8.33%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Iron dextran and have Atelectasis?

- Check whether Atelectasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Iron dextran:

Iron dextran (1,487 reports)

Atelectasis treatments and more:

Atelectasis (17,087 reports)

Browse all side effects of Iron dextran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atelectasis:

Atelectasis (1,454 drugs)

Browse all the conditions that are associated with Atelectasis:

Atelectasis (1,634 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on iron dextran (the active ingredients of Iron dextran) and Iron dextran (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.